Source - RNS
RNS Number : 9403J
Yujin International Ltd
15 September 2016






Further to the announcement on 22 August 2016, the Directors of Yujin are pleased to announce that all resolutions proposed at the two extraordinary general meetings of the Company held earlier today were duly passed.


Accordingly, cancellation of the admission to trading on AIM of the Company's shares is expected to take place at 7.30 a.m. on 23 September 2016.

In addition, the following matters, amongst others, will take effect on the admission of the Enlarged Share Capital to trading on the ISDX Growth Market, which is expected to occur at 8.00 a.m. (UK time) on 23 September 2016:

·     the consolidation of every 91 Existing Ordinary Shares into 2 New Ordinary Shares;


·     the acquisition by the Company of the entire issued share capital of Healthperm Resourcing Limited, resulting in the issue of 7,459,193 Consideration Shares (following the Share Consolidation); and


·     the Board of the Company will become:


Alan Kitchin (Non-Executive Chairman)


David Sumner (Chief Executive Officer)


John-Paul Etheridge (Chief Financial Officer)


Aamir Quraishi (Non-Executive Director)


Lee Keen Whye (Non-Executive Director)


Steven Howson (Non-Executive Director)


The change of the Company's name to Healthperm Resourcing Ltd will become effective when registered with the Singaporean Accounting and Corporate Regulatory Authority (ACRA) which is expected to take place on the date of Admission.


The Enlarged Share Capital, comprising 8,658,180 New Ordinary Shares will trade under the ISIN SG9999015259 and TIDM HPR.


Capitalised but undefined terms appearing in this announcement have the meanings set out in the Definitions section of the Admission Document.






Yujin International Ltd.

Keen Whye Lee

Tel: 00 (65) 6226 2963



Cantor Fitzgerald Europe

Rick Thompson/David Foreman/Michael Reynolds

Tel: 020 7894 7000

W H Ireland Limited

Tim Feather/Liam Gribben

Tel: 0113 394 6600



The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon publication of this announcement, this information is now considered to be in the public domain.

This information is provided by RNS
The company news service from the London Stock Exchange